First Marijuana-Based Drug Approved By FDA In Expected Move
The drug, Epidiolex, is used to treat seizures in a very small population with a rare form of epilepsy. It does not create a high for patients.
The Associated Press:
Medical Milestone: US OKs Marijuana-Based Drug For Seizures
U.S. health regulators on Monday approved the first prescription drug made from marijuana, a milestone that could spur more research into a drug that remains illegal under federal law, despite growing legalization for recreational and medical use. The Food and Drug Administration approved the medication, called Epidiolex, to treat two rare forms of epilepsy in patients 2 years and older. But it's not quite medical marijuana. (6/25)
The Washington Post:
First Marijuana-Derived Drug Approved, Will Target Severe Epilepsy
The drug, called Epidiolex, is an oral solution containing highly purified cannabidiol (CBD), which is one of scores of chemicals in the cannabis sativa plant, commonly known as marijuana. The drug contains only trace amounts of the psychoactive element THC and does not induce euphoria. Epidiolex was approved for patients age 2 and older who suffer from Lennox-Gastaut and Dravet syndromes. Both cause uncontrolled daily seizures and put patients at high risk for other physical and intellectual disabilities, injury and early death. The disorders afflict fewer than 45,000 people in the United States, but experts expect Epidiolex to be prescribed for other types of epilepsy as well. The drug is the first treatment approved for Dravet syndrome. (McGinley, 6/25)
The Wall Street Journal:
FDA Approves First Drug Derived From Marijuana Plant
The FDA said Monday that the drug doesn’t cause the high that comes from the chemical tetrahydrocannabinol, or THC, which is the main psychoactive component of marijuana. FDA officials also said the drug doesn’t appear to have abuse potential, citing minimal reports of euphoria in patients who took the drug in clinical studies. (Loftus, 6/25)